Adaptive Biotechnologies ADPT Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from Adaptive Biotechnologies’s reported figures.
Based on the most recent quarter.
The official record: Adaptive Biotechnologies’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Adaptive Biotechnologies's current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Adaptive Biotechnologies's current ratio?
- Adaptive Biotechnologies (ADPT) reported current ratio of 3.4× in Q1 2026.
- How has Adaptive Biotechnologies's current ratio changed year-over-year?
- Adaptive Biotechnologies's current ratio increased by 14.8% year-over-year, from 2.9× to 3.4×.
- What is the long-term trend for Adaptive Biotechnologies's current ratio?
- Over 5 years (2020 to 2025), Adaptive Biotechnologies's current ratio has grown at a -13.5% compound annual growth rate (CAGR), from 6.9× to 3.3×.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.